Huayuan Bio announced that the company recently obtained a Drug Manufacturing License issued by the Zhejiang Medical Products Administration, valid until August 9, 2031. This is the first time the company has received this license and passed the drug GMP compliance inspection, providing qualification assurance for its active pharmaceutical ingredients and finished drug products to obtain marketing approval and commercial production and sales, which is conducive to completing the full vitamin D3 industry chain layout. The company noted that it still needs to obtain an active pharmaceutical ingredient filing certificate before products can be marketed and sold, and this will not have a significant impact on operating performance in the short term.
Zhejiang Garden Bio-chemical High-tech Co LtdObtaining first Drug Manufacturing License and passing GMP inspection supports full vitamin D3 chain, though short-term impact limited.
